Notify me when Vaddi Krishna files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Common Stock, par value $0.0001 per share | 14% | $3,902,682 | +$554,312 | 6,397,839 | +17% | Vaddi Krishna | 31 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|